NCT04502836

Brief Summary

Over 20% of the population is reporting on "white coat syndrome", manifested as anxiety symptoms and elevated BP during interaction with medical staff. It is estimated that, throughout the life span of children, approximately 15-20% will suffer from some form of a trauma relating to an interaction with health provider. The proposed study aims is to evaluate the correlation between a single preliminary psychological intervention, including providing knowledge and tools for problems solving, and the anxiety level in female patients arriving to Adrenocorticotropic Hormone (ACTH) and Lutenising Releasing Hormone (LRH) test in comparison to the anxiety in patients arriving to the same test without psychological intervention. 20 female patients arriving to ACTH LRH test for puberty stage assessment (performed as part of routine medical care) will be recruited to the study and will be randomized to one of 2 groups. Participants in the intervention group (10 patients) will be required to arrive with their parents an hour prior to the test and will receive a preliminary psychological intervention. The control group will arrive to the ACTH LRH test on the scheduled time and will not receive psychological intervention

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 26, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 6, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

December 11, 2020

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 11, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 11, 2024

Completed
Last Updated

April 12, 2024

Status Verified

March 1, 2024

Enrollment Period

3.3 years

First QC Date

July 26, 2020

Last Update Submit

April 11, 2024

Conditions

Keywords

ACTH LRH Test

Outcome Measures

Primary Outcomes (1)

  • Anxiety Questionnaire

    Baseline (Visit 1), At the end of the ACTH LRH test, 2 hours

Secondary Outcomes (1)

  • Parents Treatment Satisfaction Questionnaire

    Baseline (Visit 1), At the end of the ACTH LRH test, 2 hours

Study Arms (2)

preliminary psychological intervention

EXPERIMENTAL

Participants in this group will receive a psychological intervention providing knowledge and tools for problems solving one hour prior to the ACTH LRH test.

Behavioral: Preliminary psychological intervention

control group

NO INTERVENTION

Participants in this group will not receive any psychological intervention prior to the test.

Interventions

psychological intervention including providing knowledge and tools for problems solving according to the Choice - Agenda - Resilience - Emotional support (CARE) model . After intervention session patients and their parents will be asked to complete questionnaires

preliminary psychological intervention

Eligibility Criteria

Age7 Years - 12 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Girls referred to ACTH LRH or LRH test
  • Age 7-12 years old
  • Ability to answer questionnaire independently (hebrew language only)

You may not qualify if:

  • Mental disability
  • Girls who were referred to the test in purpose of evaluation of the pituitary adrenal axis after prolong steroids therapy.
  • Girls with chronic disease that required frequent hospitalization (over 4 times per year)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Schneider Children's Medical Center of Israel

Petah Tikva, 4920235, Israel

Location

MeSH Terms

Conditions

Puberty, Precocious

Condition Hierarchy (Ancestors)

Gonadal DisordersEndocrine System Diseases

Study Officials

  • Moshe Phillip, Prof

    Schneider Children's Medical Center, Israel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 26, 2020

First Posted

August 6, 2020

Study Start

December 11, 2020

Primary Completion

April 11, 2024

Study Completion

April 11, 2024

Last Updated

April 12, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations